SPINK4 and rectal cancer: Since numerous SPINK members also act as inhibitors of serine protease uPA [49,50,51], whether SPINK4 can dissociate the binding between matrix-bound vitronectin and the uPA receptor to create a metastatic niche in rectal cancer needs to be confirmed.